Company Valuation: IntegraGen

Data adjusted to current consolidation scope
Fiscal Period: December 2019 2020
Market Cap 1 6.536 13.61
Change - 108.2%
Enterprise Value (EV) 1 4.017 10.5
Change - 161.33%
P/E -23x -36.6x
PBR 2.61x 6.28x
PEG - -1.3x
Capitalization / Revenue 0.79x 1.51x
EV / Revenue 0.49x 1.17x
EV / EBITDA -37.6x -375x
EV / EBIT -11.1x -41.2x
EV / FCF - -
FCF Yield - -
Dividend per Share 2 - -
Rate of return - -
EPS 2 -0.0439 -0.0559
Distribution rate - -
Net sales 1 8.28 9
EBITDA 1 -0.107 -0.028
EBIT 1 -0.3631 -0.255
Net income 1 -0.2848 -0.375
Net Debt 1 -2.519 -3.109
Reference price 2 1.0100 2.0500
Nbr of stocks (in thousands) 6,471 6,638
Announcement Date 4/3/20 6/11/21
1EUR in Million2EUR
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 500K
21.73x7.72x15.51x1.37% 74.31B
29.59x8.5x26.48x0.04% 56.95B
33.52x6.02x18.04x0.97% 48.3B
-21.51x223.61x-23.09x-.--% 44.51B
34.27x3.31x14.29x-.--% 43.8B
47.24x5.47x29.99x-.--% 41.12B
27.63x7.93x20.48x0.41% 31.07B
33.5x7.16x18.6x-.--% 28.97B
-15.28x5.82x-7.31x-.--% 24.53B
Average 21.19x 30.62x 12.55x 0.31% 39.36B
Weighted average by Cap. 22.51x 31.17x 13.62x 0.42%

Y-o-Y evolution of P/E

Valuation ratios - P/E - IntegraGen

Historical PBR trend

Valuation ratios - PBR - IntegraGen

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - IntegraGen

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - IntegraGen